Penicillin is the drug of choice for the treatment of Streptococcus pyogenes infection. However, for patients sensitive to ␤-lactam antibiotics, and when these drugs fail, macrolides are often the recommended substitute. Penicillin resistance has not yet been described in S. pyogenes, but resistance to erythromycin and related antibiotics has been widely reported (2, 3, 5, 8, 10, 11, 17, 20, 29, 33, 43, 46) . The mechanism of acquired resistance to erythromycin involves a target site modification mediated by a methylase which modifies the 50S ribosomal subunit, leading to the MLS B resistance phenotype encoded by erm genes (25, 36, 47) . Erythromycin resistance due to an efflux mechanism (M phenotype), encoded by mef genes, has recently been described (6, 45) . While the prevalence of the S. pyogenes resistance to macrolides has been reported worldwide, very few recent data deal with the French situation (1, 8) . The aims of this study were to assess the macrolide sensitivity of recent throat isolates of S. pyogenes collected from French children, to determine the genetic mechanisms of resistance, and to explore clonality by means of serotyping and molecular methods.
MATERIALS AND METHODS

Bacterial isolates.
A total of 1,500 consecutive S. pyogenes isolates were collected between 1996 and 1999 throughout France. They were isolated by swabbing the throats of children, 4 to 17 years old (mean age, 11 years), with pharyngitis. The isolates were identified as S. pyogenes by colony morphology, beta-hemolysis on blood agar, and a commercial agglutination technique (Murex Diagnostics UK).
Susceptibility testing. The procedures for susceptibility testing were those recommended by the National Committee for Clinical Laboratory Standards (NCCLS) (30) .
(i) Detection of erythromycin resistance and determination of resistance phenotypes. Erythromycin-resistant strains were initially identified by the disk diffusion method on Mueller-Hinton agar supplemented with 5% defibrinated horse blood (Diagnostic Pasteur, Marnes la Coquette, France) using 15-g erythromycin disks (Diagnostic Pasteur) according to NCCLS guidelines (30) . Simultaneously, the resistance phenotypes of erythromycin-resistant S. pyogenes isolates were determined by the double-disk test with erythromycin and clindamycin disks, as previously described (42) . Blunting of the clindamycin inhibition zone proximal to the erythromycin disk indicated an inducible type of MLS B resistance, and resistance to both erythromycin and clindamycin indicated a constitutive type of MLS B resistance. Susceptibility to clindamycin with no blunting indicated the new erythromycin resistance phenotype (M phenotype).
(ii) Determination of MICs. The MICs of erythromycin (Roussel Uclaf, Paris, France), azithromycin (Pfizer, Orsay, France), josamycin (Rhône-Poulenc-Rorer, Vitry-sur-Seine, France), clindamycin (Pharmacia Upjohn, Saint-Quentin-enYvelines, France), and streptogramin B (Rhône-Poulenc-Rorer) were determined for all the isolates that had an erythromycin inhibition zone diameter of less than 21 mm (30). MICs were determined by the agar dilution method with Mueller-Hinton medium supplemented with 5% defibrinated sheep blood. The plates were incubated overnight at 35°C in ambient air. The NCCLS breakpoints for resistance (30) were as follows: susceptible (MIC Յ 0.25 g/ml) or resistant (MIC Ն 1 g/ml) to erythromycin and clindamycin and susceptible (MIC Յ 0.5 g/ml) or resistant to azithromycin (MIC Ն 2 g/ml). Given the lack of NCCLS recommendations on josamycin, we used the breakpoints recommended by the Comité de l'Antibiogramme de la Société Française de Microbiologie (9), i.e., a susceptibility MIC of Յ1 g/ml and a resistance of MIC Ն4 g/ml.
Detection of erythromycin resistance genes. All erythromycin-resistant isolates were screened for erythromycin resistance genes. Isolates were grown in 20 ml of TGY broth (Diagnostic Pasteur) for 18 h. After centrifugation, bacterial DNA was prepared as previously described (4) . The mef, erm, and ermTR genes were detected by PCR amplification, using previously published primers (24, 36) . We used 5Ј-AGT ATC ATT AAT CAC TAG TGC-3Ј and 5Ј-TTC TTC TGG TAC TAA AAG TGG-3Ј to detect mefA, 5Ј-CGA GTG AAA AAG TAC TCA ACC-3Ј and 5Ј-GGC GTG TTT CAT TGC TTG ATG-3Ј to detect ermB, and 5Ј-GCA TGA CAT AAA CCT TCA-3Ј and 5Ј-AGG TTA TAA TGA AAC AGA-3Ј to detect ermTR. Amplification was performed in a DNA thermal cycler (no. 9600; Perkin-Elmer Cetus, Norwalk, Conn.) programmed for one cycle of denaturation at 95°C for 2 min followed by 30 cycles of denaturation at 95°C for 1 min, primer annealing at 55°C for 2 min, and extension at 72°C for 10 min (24) . Amplification products were run through 1% agarose gels. Gels were stained with ethidium bromide, and the DNA bands were visualized with a UV transilluminator. S. pyogenes 02C 1061, S. pyogenes 02 61110 and S. pyogenes 02C 1064 were used as positive PCR controls for the ermB, ermTR, and mefA genes, respectively (6, 7, 12, 44) . Five erythromycin-susceptible S. pyogenes isolates were used as negative controls. Amplification of DNA from the positive controls with the corresponding primers produced PCR products of expected sizes (616, 348, and 206 bp for erm, mef, and ermTR, respectively) ( Fig. 1 ). These PCR products were used for direct sequencing with an Applied Biosystems model 373 sequencer, using a modification of the method of Sanger et al. (35) . The analysis showed that the amplimers were identical to mefA, ermB, and ermTR genes (6, 36, 47) .
After amplification, hybridization with DNA probes was performed for the mef and erm PCR products. The PCR products were transferred, by using a standard method, to Hybond-Nϩ membranes (Amersham Bioproducts). The 616 and 348-bp PCR product from S. pyogenes 02C 1061 and 02C 1064, respectively, were chemiluminescence labeled according to the manufacturer's instructions and hybridized to the PCR products from each of the erythromycin-resistant isolates.
No hybridization was observed with the five erythromycin-susceptible control isolates.
Restriction fragment length polymorphism analysis of the mef and erm PCR products. The PCR products of the erythromycin resistance genes mef and erm from 15 randomly selected isolates were digested by MseI and Tsp509I (mefA) or FokI and SauIII (ermB), and electrophoresis on 6% polyacrylamide gel was performed as previously described (13) . Gels were stained with ethidium bromide, and DNA bands were visualized with a UV transilluminator.
Serotyping. Erythromycin-resistant S. pyogenes isolates were studied by T and M serotyping, and the presence of serum opacity factor was also determined as previously described (23) , in the Colindale laboratory (Central Public Health Laboratory, London, United Kingdom).
Genotyping. Genotyping based on restriction fragment length polymorphism of the rRNA gene (ribotyping) was performed on all the erythromycin-resistant isolates. DNA was digested with HindIII and HhaI (Boehringer, Mannheim, Germany) according to the manufacturer's instructions and analyzed by Southern blotting with a chemiluminescent ribosomal probe, as previously described (4) . Initial experiments on a few strains showed that HindIII produced a better distribution of restriction length fragments than did HhaI. HindIII was thus used to ribotype all the strains.
RESULTS
Antimicrobial susceptibility patterns of and MICs for the S. pyogenes isolates with different erythromycin resistance phenotypes. The screening plate method showed that 6.2% (93 of 1,500) of the S. pyogenes isolates had decreased susceptibility to erythromycin. Among those isolates, 3.4% (51 of 1,500) and 2.8% (42 of 1,500) expressed the constitutive MLS B and M resistance phenotypes, respectively. None of the isolates had the inducible MLS B resistance phenotype. Table 1 shows the MICs for S. pyogenes according to the erythromycin resistance phenotype. All 93 strains were resistant to erythromycin (MIC breakpoint Ն1 g/ml).
Isolates with the MLS B phenotype were resistant to the 14-, 15-and 16-membered-ring macrolides (azithromycin and josamycin, respectively) and showed cross-resistance to clindamycin and streptogramin B. Isolates with the M phenotype were resistant to erythromycin and azithromycin, but the 16-membered-ring macrolides josamycin and clindamycin showed good activity against these isolates.
Erythromycin resistance genes of S. pyogenes isolates with different erythromycin resistance phenotypes. PCR amplification followed by Southern hybridization showed that all the resistant isolates with the MLS B and M phenotypes harbored the ermB and mefA genes, respectively. Digestion of mef PCR products by MseI and Tsp5091 produced a single restriction pattern. We also observed a single restriction pattern when erm PCR products were digested by FokI and SauIII. PCR amplification with primers corresponding to ermTR identified only one isolate harboring this gene. Interestingly, this isolate also harbored the ermB gene.
Genotyping. After digestion by HindIII, a total of 8 ribotypes (A to H) were observed among the 93 erythromycin-resistant isolates. Twenty-nine (31%), 20 (22%), 12 (13%), and 28 (30%) of the 93 erythromycin-resistant strains belonged to ribotypes A, G, E, and C, respectively. Four isolates (4%) had unique individual patterns. The ribotype distribution according to the genetic mechanism of resistance is reported in Table 2 . The mefA gene was recovered from six clusters, with one being predominant, while the ermB gene was recovered from four clusters, with two being predominant.
Serotyping. Serotyping identified 10 serotypes (Table 3) . Thirty-two isolates (34%) were of serotype T4M4, 18 (19%) were of serotype T12M22, 12 (13%) were of serotype T12M12, 12 (13%) were of serotype T28R28, 5 (5%) were of serotype T2M2, 8 (9%) were of serotype T11M11, 3 (3%) were of serotype T1M1, and one each was of serotype T6M6, T22M22, and T13M77. No apparent geographic clustering of isolates of any serotype was observed.
The serum opacity factor typing was positive for all the isolates of serotypes T2M2, T4M4, T11M11, T12M22, and T28R28.
A strong correlation of some serotypes with particular erythromycin-resistance genotypes was found, as the gene mefA was present in all but one of the serotype T4M4 isolates and all the serotype T1M1 isolates. The ermB gene was found in all the isolates of serotypes T11M11, T12M22, and T28R28 and in all but one of the serotype T2M2 isolates. The number of ribotypes within each serotype varied between one and four. The combination of ribotyping and serotyping allowed us to identify 17 strains (Table 3) . Seventy percent of macrolide resistance due to mefA was due to T4M4 ribotype A, and 60% of ermB resistance was found in two clones.
DISCUSSION
Although S. pyogenes is consistently susceptible to penicillin, resistance to macrolides, first described in the United Kingdom in 1958 (26) and in the United States in 1968 (34), has been reported worldwide. The incidence of S. pyogenes erythromycin resistance remains low in most parts of the world but recently reached 17% in Finland (23), 27 to 34% in Spain (2, 32, 33) , and 30 to 35% in Italy (5, 11) . In our study, the prevalence of erythromycin resistance in S. pyogenes isolates from French children was only 6.2%. Similar percentages (4 to 10%) have been reported in Germany (G. Cornaglia, P. Huovinen, and The European GAS Study Group, Abstr. 38th Intersci. Conf. Antimicrob. Agents Chemother., abstr. E-149, 1998), the United Kingdom ( . The latest gene in that class is designated ermTR (36) . An efflux mechanism of resistance encoded by the mefA gene has also been reported (6) . The gene encodes a hydrophobic 44.2-kDa protein sharing homology with membrane-associated pump proteins (6) . The ermB and mefA genes were harbored by 3.4 and 2.8% of our isolates, respectively, conferring the MLS B and M phenotypes. Contrary to a previous report, none of our strains harbored both the ermB and mefA genes (18) . However, the isolate which carried ermTR also harbored ermB, as previously observed (E. Di Modugno, A. Felici, M. Guerrini, H. Mottl, P. Piccoli, and D. Sabatini, Program Abstr. 5th Int. Conf. Macrolides, Azalides, Streptogramins, Ketolides, Oxazolidinones, abstr. 7.14, 2000). The M phenotype was found to be predominant among erythromycin-resistant S. pyogenes isolates in Finland (23), Sweden (20) , Spain (32) , and some areas in Italy (5), while an equal distribution of the M and inducible MLS B phenotypes was reported in Greece (46) . Genetic investigations were made in Finland and Spain and showed the predominance of the mefA gene (23, 32) . In agreement with previous studies (22, 33) , the ermB gene conferred coresistance to 14-, 15-, and 16-membered-ring macrolides and lincosamides (MICs at which 90% of the isolates tested are inhibited [MIC 90 s] exceeding 128 g/ml for both drugs), and to streptogramin B (MIC 90 ϭ 64 g/ml); the mefA gene conferred resistance only to 14-and 15-membered-ring macrolides (MIC 90 ϭ 8 g/ml).
Previous reports have suggested that erythromycin resistance is often associated with specific serotypes (21) . Indeed, the increase in erythromycin resistance among S. pyogenes isolates has been linked to the spread of serotype T12 in Japan (27, 28, 29) and serotype T4M4 in Finland (23) . Eight T and 9 M agglutination patterns were observed in our study among the 93 erythromycin-resistant isolates.
Although serotyping has provided useful epidemiologic information, its discriminatory power is considered poor because of genetic heterogeneity among isolates of the same serotype on the one hand and the existence of the same genotype among different serotypes on the other hand. Genomic typing methods such as restriction endonuclease analysis (REA), random amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis have been applied to S. pyogenes, together with ribotyping (15, 32, 40, 41) . Ribotyping was found to be less discriminatory than REA (4). However, the complexity of the restriction patterns makes it difficult to analyze a large number of isolates by REA. We used ribotyping for strain differentiation, identifying eight ribotypes among the 93 erythromycinresistant S. pyogenes isolates. We combined ribotyping and serotyping. In 3 out of 10 cases, ribotyping revealed genetic differences among isolates of the same serotype. Although ribotyping identified many different clones within a single serotype, identical ribotypes were detected among isolates of different serotypes. Analysis of the M protein sequences has shown that some serotypes are phylogenetically closer than others (14) . Ribotyping adds to the discriminatory power of serotyping, especially when epidemiologically unrelated isolates are compared (41); we identified 17 different strains in this way.
Six of the eight ribotypes carried either the mefA or the ermB gene. The mefA gene was recovered from six clusters. One cluster was predominant, and most of the strains were serotype T4M4. In Finland, the increase in erythromycin-resistant S. pyogenes with the M phenotype was also due to strains of serotype T4M4 (23) . The ermB gene was recovered from four clusters, two being predominant. Thus, most isolates carrying the mefA gene were unrelated to those harboring the ermB gene. The location of erm and possibly mef on a chromosomal conjugative transposon may explain the spread of erythromycin resistance to different clones of S. pyogenes (25) . The isolate harboring ermTR was of serotype M28T28. Interestingly, the resistance of S. pyogenes to macrolides in Quebec, Canada, is due to a single M28T28 clone possessing the ermTR gene (K. Weiss et al., 5th ICMASKO).
Macrolide resistance is closely related to the extent to which these agents are used, and national surveys have shown that decreases in macrolide use lead to decreases in the incidence of macrolide resistance (16, 37, 39) . Moreover, a significant negative correlation has been found between the age of pa- tients and the occurrence of erythromycin-resistant organisms (38) . This seems to be the result of prescription of more antibiotics for children together with a greater risk of cross-colonization among children than among adults. The fact that the level of erythromycin resistance among our S. pyogenes isolates was below 7% may be related to the stable consumption of macrolides in France since 1980 (19, 31) and to the absence of clonal spread of erythromycin-resistant strains. The pharyngeal origin of all our isolates may also explain the relatively low incidence of erythromycin resistance, as a significantly higher rate of resistance is observed with invasive strains (43, 48) . However, it has been suggested that strain virulence is not related to antimicrobial resistance (21) .
In conclusion, we found a low level of erythromycin resistance in S. pyogenes in France. Moreover, as only 2.8% of the isolates had the M phenotype, clindamycin and josamycin would be the drugs of choice for treating children with clinical failure after phenoxymethyl penicillin, and for penicillin-allergic patients. Further careful surveillance of erythromycin resistance with other macrolides-lincosamides-streptogramin B is required to follow changes in S. pyogenes resistance patterns in France.
